Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands

Details for Australian Patent Application No. 2009239575 (hide)

Owner Bristol-Myers Squibb Company

Inventors King, Dalton; Wang, Nenghui; Macor, John E.; Cook Ii, James H.; McDonald, Ivar M.; Iwuagwu, Christiana I.; Zusi, F. Christopher; Olson, Richard E.

Agent A J Park

Pub. Number AU-A-2009239575

PCT Pub. Number WO2009/131926

Priority 61/047,211 23.04.08 US; 12/423,299 14.04.09 US

Filing date 20 April 2009

Wipo publication date 29 October 2009

International Classifications

C07D 498/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2009/131926 Priority application(s): WO2009/131926

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009239576-Dual spray can topical delivery device

2009239567-Multiple battery system for a motor vehicle